Longevity Health Holdings, Inc.
Close on Oct 19, 2026
- Market cap
- $277.24K
- P/E (TTM)
- –
- Dividend yield
- –
About Longevity Health
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics, SIC 2840
Longevity Health Holdings, Inc. develops and commercializes regenerative bio-aesthetic products focused on healthy aging, alongside a pipeline of bone and tissue healing technologies. The company operates in a single segment dedicated to these therapeutic and aesthetic categories. Its primary commercial offerings comprise two cosmetic lines, Elevai Exosomes and Carmell Secretome, which provide skincare and haircare solutions including post-treatment serums, daily aftercare lotions, cleansers, and scalp treatments. The company serves professional healthcare providers, such as dermatologists and plastic surgeons in medical spas and clinics, alongside retail consumers through online channels and distribution partners.
The company manufactures its cosmetic formulations within facilities situated in the United States and distributes products domestically and to international markets through distributor agreements. Operations are supported by ten full-time employees. The company maintains its principal corporate office in Pittsburgh, Pennsylvania.
Summary of the business section of Longevity Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Longevity Health Holdings, Inc.
- Founded
- 2008
- Headquarters
- Pittsburgh, PA
- Address
- 2403 Sidney Street, Suite 300 15203
- Phone
- (412) 894-8248
- Website
- carmellcorp.com
- Employees
- 10, Dec 31, 2025
- Industry
- Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Adeptus Partners, LLC, Ocean, New Jersey
Stock & identifiers
- Ticker
- XAGE
- Other tickers
- XAGEW
- Exchange
- OTC
- IPO date
- Jul 27, 2021
- Shares outstanding
- 2M, Aug 13, 2026
- Public float
- $3.30M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-30 reverse, May 15, 2025; 1-for-30 reverse, May 14, 2025
- SEC CIK
- 1842939
- CUSIP
- 142922129
- ISIN
- US1429221294
- EIN
- 86-1645738
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| J. Ram Ajjarapu | Chief Executive Officer, Director | 689,656 |
| Rajiv Shukla | Chairman and CEO, Director | 7,578,561 |
| Bryan J. Cassaday | Chief Financial Officer | 4,250 |
| Kendra Bracken-Ferguson | Chief Executive Officer | – |
| Kathryn Gregory | Director | 84,757 |
| Scott M. Frisch | Director | 28,419 |
| Gilles Spenlehauer | Director | 28,419 |
| Patrick A. Sturgeon | Director | 115,089 |
| Richard A. Upton | Director | 1,373,019 |
Employees
Headcount reported in annual reports
“As of March 27, 2026, we have ten full-time employees.”
Corporate history
Events identified from SEC filings